BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Dupixent Discussions - ECPv6.15.18//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Dupixent Discussions X-ORIGINAL-URL:https://www.dupixentdiscussions.com X-WR-CALDESC:Events for Dupixent Discussions REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Chicago BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20240310T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20241103T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20250309T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20251102T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20260308T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20261101T070000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20251002T121500 DTEND;TZID=America/New_York:20251002T131500 DTSTAMP:20260405T125633 CREATED:20250829T203258Z LAST-MODIFIED:20250926T005252Z UID:10000716-1759407300-1759410900@www.dupixentdiscussions.com SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Justin Greiwe\, MD DESCRIPTION:Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation\n\n \n \n Attendee Registration\n \n \n FacebookThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-justin-greiwe-md/ LOCATION:Virtual (Zoom) CATEGORIES:Chronic Spontaneous Urticaria (CSU) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Justin-Greiwe-wdrEP0.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Chicago:20251001T121500 DTEND;TZID=America/Chicago:20251001T131500 DTSTAMP:20260405T125633 CREATED:20250829T203257Z LAST-MODIFIED:20250919T211028Z UID:10000715-1759320900-1759324500@www.dupixentdiscussions.com SUMMARY:Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age by Raj Chovatiya\, MD DESCRIPTION:Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU)\, including its clinical manifestations\, diagnostic evaluation\, assessment scales\, and a treatment option for appropriate CSU patients 12+ years of age. \n\n \n \n Attendee Registration\n \n \n InstagramThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-raj-chovatiya-md/ LOCATION:Virtual (Zoom) CATEGORIES:Chronic Spontaneous Urticaria (CSU) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Raj-Chovatiya-1-e1705617016350-65OSWK.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250930T121500 DTEND;TZID=America/Los_Angeles:20250930T131500 DTSTAMP:20260405T125633 CREATED:20250829T203257Z LAST-MODIFIED:20250926T005136Z UID:10000714-1759234500-1759238100@www.dupixentdiscussions.com SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Kathryn Sowerwine\, MD DESCRIPTION:Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation\n \n \n Attendee Registration\n \n \n NameThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-kathryn-sowerwine-md/ LOCATION:Virtual (Zoom) CATEGORIES:Chronic Spontaneous Urticaria (CSU) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Kathryn-Sowerwine-e1705692143713-eb2DRh.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20250929T121500 DTEND;TZID=America/New_York:20250929T124500 DTSTAMP:20260405T125633 CREATED:20250829T203257Z LAST-MODIFIED:20250926T005114Z UID:10000713-1759148100-1759149900@www.dupixentdiscussions.com SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Andrew Mastro\, PA-C DESCRIPTION:This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. \nRegister \n  URL:https://www.dupixentdiscussions.com/event/exploring-the-pathophysiology-of-type-2-inflammation-in-chronic-spontaneous-urticaria-csu-and-a-treatment-option-for-appropriate-csu-patients-12-years-of-age-by-andrew-mastro-pa-c/ LOCATION:Virtual (Zoom) CATEGORIES:Chronic Spontaneous Urticaria (CSU) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Andrew-Mastro-PA-C-e1756498706590.png END:VEVENT END:VCALENDAR